Nicotine metabolism in healthy smokers and patients with cardiovascular diseases

In this study, we measured the excretion rate of nicotine and its two major metabolites, cotinine and trans-3′-hydroxycotinine (THOC), in the urine of 25 healthy smokers and 15 smokers who underwent a coronary artery bypass surgery or coronary angioplasty. After 1 day of smoking cessation, urine sam...

Full description

Saved in:
Bibliographic Details
Main Author: Chahine, Ramez (author)
Other Authors: Abchee, Antoine (author), Zalloua, Pierre (author)
Format: article
Published: 2005
Online Access:http://hdl.handle.net/10725/11114
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s11010-005-8840-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513488282451968
author Chahine, Ramez
author2 Abchee, Antoine
Zalloua, Pierre
author2_role author
author
author_facet Chahine, Ramez
Abchee, Antoine
Zalloua, Pierre
author_role author
dc.creator.none.fl_str_mv Chahine, Ramez
Abchee, Antoine
Zalloua, Pierre
dc.date.none.fl_str_mv 2005
2019-07-22T07:15:57Z
2019-07-22T07:15:57Z
2019-07-22
dc.identifier.none.fl_str_mv 1573-4919
http://hdl.handle.net/10725/11114
Chahine, R., Abchee, A., & Zalloua, P. (2005). Nicotine metabolism in healthy smokers and patients with cardiovascular diseases. Molecular and cellular biochemistry, 280(1-2), 241-244.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s11010-005-8840-9
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Molecular and Cellular Biochemistry
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description In this study, we measured the excretion rate of nicotine and its two major metabolites, cotinine and trans-3′-hydroxycotinine (THOC), in the urine of 25 healthy smokers and 15 smokers who underwent a coronary artery bypass surgery or coronary angioplasty. After 1 day of smoking cessation, urine samples were collected in the morning, before smoking two cigarettes, and then three times after smoking, approximately 4 h apart. The results show that (i) in healthy smokers, nicotine and its two major metabolites were present at high concentration in the first urine sample after smoking, (ii) in smokers with cardiovascular disease nicotine and cotinine were less excreted whereas THOC was more excreted, mainly in the second urine sample. We conclude that this shift in nicotine metabolism may contribute to smoking-induced cardiovascular disease.
eu_rights_str_mv openAccess
format article
id LAURepo_38f1b11707cdce58ab369d7e09db0d55
identifier_str_mv 1573-4919
Chahine, R., Abchee, A., & Zalloua, P. (2005). Nicotine metabolism in healthy smokers and patients with cardiovascular diseases. Molecular and cellular biochemistry, 280(1-2), 241-244.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/11114
publishDate 2005
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Nicotine metabolism in healthy smokers and patients with cardiovascular diseasesChahine, RamezAbchee, AntoineZalloua, PierreIn this study, we measured the excretion rate of nicotine and its two major metabolites, cotinine and trans-3′-hydroxycotinine (THOC), in the urine of 25 healthy smokers and 15 smokers who underwent a coronary artery bypass surgery or coronary angioplasty. After 1 day of smoking cessation, urine samples were collected in the morning, before smoking two cigarettes, and then three times after smoking, approximately 4 h apart. The results show that (i) in healthy smokers, nicotine and its two major metabolites were present at high concentration in the first urine sample after smoking, (ii) in smokers with cardiovascular disease nicotine and cotinine were less excreted whereas THOC was more excreted, mainly in the second urine sample. We conclude that this shift in nicotine metabolism may contribute to smoking-induced cardiovascular disease.PublishedN/A2019-07-22T07:15:57Z2019-07-22T07:15:57Z20052019-07-22Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1573-4919http://hdl.handle.net/10725/11114Chahine, R., Abchee, A., & Zalloua, P. (2005). Nicotine metabolism in healthy smokers and patients with cardiovascular diseases. Molecular and cellular biochemistry, 280(1-2), 241-244.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://link.springer.com/article/10.1007/s11010-005-8840-9enMolecular and Cellular Biochemistryinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/111142021-03-19T10:47:35Z
spellingShingle Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
Chahine, Ramez
status_str publishedVersion
title Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
title_full Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
title_fullStr Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
title_full_unstemmed Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
title_short Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
title_sort Nicotine metabolism in healthy smokers and patients with cardiovascular diseases
url http://hdl.handle.net/10725/11114
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s11010-005-8840-9